CDC Report Addresses Nonfinancial Access Barriers to Care in 2022
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 1, 2024 -- Nonfinancial access barriers to care represent a persistent problem in the United States, with more than 12 percent of adults reporting being too busy to go to a provider, according to a study published online Aug. 1 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.
Amanda E. Ng, Ph.D., M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from the 2022 National Health Interview Survey to estimate the percentage of adults who delayed or did not get medical care in the past 12 months because of five nonfinancial access barriers to care.
The researchers found that 12.5 percent of U.S. adults delayed or did not get medical care in the past 12 months because they were too busy to go to a provider; 10.6, 4.6, 4.4, and 2.4 percent could not find an available appointment when needed, were unable to get to a provider when open, had difficulty finding a doctor compatible with their health insurance, and noted that it takes too long to get to a provider, respectively. There was variation observed in the percentages by sociodemographic characteristics.
"Focusing on nonfinancial access barriers to care, in addition to financial barriers, is important for informing why adults in the United States may have unmet care needs, and for bridging existing disparities in access," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-02 01:15
Read more
- American College of Chest Physicians, Oct. 6-9
- Early TAVR Beneficial for Asymptomatic Severe Aortic Stenosis
- Florida Fails to Pass Amendment Legalizing Recreational Weed
- Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
- Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
- Computer-Aided Detection Colonoscopies Tied to Improved Adenoma Detection Rate
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions